FDASM: Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools
The US Food and Drug Administration (FDA) held a public forum on November 12th and 13th to solicit input from stakeholders to inform the development of policies and guidelines for the use of social media in health care and pharmaceutical industries and environments.
Whatever policies are developed will have the potential to impact healthcare-related communication processes much as HIPAA has. Public responses are due to the FDA in February. The University of Michigan community is encouraged to contribute to this conversation.
The webcast archive of the public forum will only be available through mid-December. The UM Health Sciences Libraries, UMHS Public Relations & Marketing, and UMMS Office of Enabling Technologies are partnering on providing an opportunity to view the complete webcast as a community as part of formulating our own responses and informing the process of developing local best practices for use of social media in health care environments, and in preparation for a January community forum on this topic. Highpoints from viewings and discussion will hopefully be posted on this blog (Emerging Technologies Librarian).
The webcast will be viewed in eight sequential sections. Viewing sessions are open to the public. See below for information on individual sessions. People may also view the webcast sessions on their own. Discussion and backchat at the viewings is encouraged.
Here is the main website from the FDA about the public forum and with the link to the archived webcast.
Here is the link to the archived Twitter backchat:
Transcript of backchat just during the two-day public forum
Here is the official site:
Federal Register Notice of Public Hearing: